# Stage Ib Trial of mSMART With Varenicline

> **NCT03069768** · PHASE1 · WITHDRAWN · sponsor: **Duke University**

## Conditions studied

- Nicotine Dependence

## Interventions

- **DEVICE:** mSMART
- **DRUG:** Chantix

## Key facts

- **NCT ID:** NCT03069768
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-04
- **Primary completion:** 2019-01
- **Final completion:** 2019-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to obtain varenicline to provide to participants
- **Last updated:** 2018-04-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03069768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03069768, "Stage Ib Trial of mSMART With Varenicline". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03069768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*